UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effectiveness and safety of anlotinib with or without S-1 in the treatment of patients with advanced hepatocellular carcinoma in a Chinese population: a prospective, phase 2 study

Radiology and oncology, 2023-09, Vol.57 (3), p.405-410

2023

Volltextzugriff (PDF)

Pembrolizumab enhances the anti-pancreatic cancer activity of anlotinib

Asian journal of surgery, 2022-03, Vol.45 (3), p.881-882

2022

Volltextzugriff (PDF)

Recombinant Human IL-11 Promotes Lung Adenocarcinoma A549 Cell Growth and EMT through Activating STAT3/HIF-1α/EMT Signaling Pathway

Anti-cancer agents in medicinal chemistry, 2021-01, Vol.21 (15), p.1996-2003

2021

Volltextzugriff (PDF)

Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region–anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib

Frontiers in oncology, 2022-10, Vol.12

2022

Volltextzugriff (PDF)

Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma

Molecules and Cells, 2017, 40(11), , pp.847-854

2017

Volltextzugriff (PDF)

A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221122715-17588359221122715

2022

Volltextzugriff (PDF)

Efficacy and safety of nab-paclitaxel+cisplatin/nedaplatin + S-1 as an induction chemotherapy regimen for locally advanced hypopharyngeal cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18050-e18050

2023

Volltextzugriff (PDF)

LncRNA DGCR5 regulates the non‐small cell lung cancer cell growth, migration, and invasion through regulating miR‐211‐5p/EPHB6 axis

BioFactors (Oxford), 2019-09, Vol.45 (5), p.788-794

2019

Volltextzugriff (PDF)

MicroRNA-211 Promotes Non-Small-Cell Lung Cancer Proliferation and Invasion by Targeting MxA [Retraction]

OncoTargets and therapy, 2022-11, Vol.15, p.1387-1388

2022

Volltextzugriff (PDF)

Deletion of IL-27p28 induces CD8 T cell immunity against colorectal tumorigenesis

International immunopharmacology, 2024-02, Vol.128, p.111464-111464, Article 111464

2024

Volltextzugriff (PDF)

Efficacy and safety of KN046, a novel bispecific antibody against PD-L1 and CTLA-4, in patients with non-small cell lung cancer who failed platinum-based chemotherapy: a phase II study

European journal of cancer (1990), 2023-09, Vol.190, p.112936-112936, Article 112936

2023

Volltextzugriff (PDF)

Efficacy of cadonilimab and anlotinib combination in treating multiple drug‑resistant pulmonary large cell neuroendocrine carcinoma: A case report and literature review

Oncology letters, 2024-10, Vol.29 (1), Article 27

2024

Volltextzugriff (PDF)

Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.1073-1085

2024

Volltextzugriff (PDF)

Integrative analyses of RNA-seq and ChIP-seq Reveal MITF as a Target Gene of TFPI-2 in MDA231 Cells

Biochemical genetics, 2023-10, Vol.61 (5), p.1745-1757

2023

Volltextzugriff (PDF)

MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA

OncoTargets and therapy, 2017, Vol.10, p.5667-5675

2017

Volltextzugriff (PDF)

Overexpression of STAT3/pSTAT3 was associated with poor prognosis in gastric cancer: a meta-analysis

International journal of clinical and experimental medicine, 2015-01, Vol.8 (11), p.20014-20023

2015

Volltextzugriff (PDF)

Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma

Molecules and cells, 2017, Vol.40 (11), p.847-854

2017

Volltextzugriff (PDF)

Evaluation of efficacy of gefitinib on advanced non-small-cell lung cancer(NSCLC) resisted to chemotherapy.

Zhongguo fei ai za zhi, 2008-04, Vol.11 (2), p.292-293

2008

Volltextzugriff (PDF)

Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial

Cancer communications (London, England), 2021-09, Vol.41 (9), p.889-903

2021

Volltextzugriff (PDF)

The Effect of Pravastatin on Expression of Platelet-Derived Endothelial Nitric Oxide Synthase(eNOS) m-RNA and Atherosclerosis Course in Rabbits

Blood, 2004-11, Vol.104 (11), p.3881-3881

2004

Volltextzugriff (PDF)

Evaluation of efficacy of gefitinib on advanced non-small-cell lung cancer?NSCLC?resisted to chemotherapy

Zhongguo fei ai za zhi, 2008-03, Vol.11 (2)

2008

Volltextzugriff (PDF)

Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region-anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib

Frontiers in oncology, 2022, Vol.12, p.1019624-1019624

2022

Volltextzugriff (PDF)

负载PbO催化剂对苯胺与碳酸二甲酯合成苯氨基甲酸甲酯的催化性能

Chinese journal of catalysis, 2007, Vol.28 (1), p.5-9

康武魁康涛马飞赵永峰崔黎黎姚洁王公应

2007

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effectiveness and safety of anlotinib with or without S-1 in the treatment of patients with advanced hepatocellular carcinoma in a Chinese population: a prospective, phase 2 study

Pembrolizumab enhances the anti-pancreatic cancer activity of anlotinib

Recombinant Human IL-11 Promotes Lung Adenocarcinoma A549 Cell Growth and EMT through Activating STAT3/HIF-1α/EMT Signaling Pathway

Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region–anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib

Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma

A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer

Efficacy and safety of nab-paclitaxel+cisplatin/nedaplatin + S-1 as an induction chemotherapy regimen for locally advanced hypopharyngeal cancer

LncRNA DGCR5 regulates the non‐small cell lung cancer cell growth, migration, and invasion through regulating miR‐211‐5p/EPHB6 axis

MicroRNA-211 Promotes Non-Small-Cell Lung Cancer Proliferation and Invasion by Targeting MxA [Retraction]

Deletion of IL-27p28 induces CD8 T cell immunity against colorectal tumorigenesis

Efficacy and safety of KN046, a novel bispecific antibody against PD-L1 and CTLA-4, in patients with non-small cell lung cancer who failed platinum-based chemotherapy: a phase II study

Efficacy of cadonilimab and anlotinib combination in treating multiple drug‑resistant pulmonary large cell neuroendocrine carcinoma: A case report and literature review

Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial

Integrative analyses of RNA-seq and ChIP-seq Reveal MITF as a Target Gene of TFPI-2 in MDA231 Cells

MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA

Overexpression of STAT3/pSTAT3 was associated with poor prognosis in gastric cancer: a meta-analysis

Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma

Evaluation of efficacy of gefitinib on advanced non-small-cell lung cancer(NSCLC) resisted to chemotherapy.

Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial

The Effect of Pravastatin on Expression of Platelet-Derived Endothelial Nitric Oxide Synthase(eNOS) m-RNA and Atherosclerosis Course in Rabbits

Evaluation of efficacy of gefitinib on advanced non-small-cell lung cancer?NSCLC?resisted to chemotherapy

Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region-anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib

负载PbO催化剂对苯胺与碳酸二甲酯合成苯氨基甲酸甲酯的催化性能

Suchergebnisse filtern